The companies that are able to consistently find good licensing opportunities are the ones that assess programmes throughout the clinical drug development process and consider the scientific evidence, the clinical, competitive and market intelligence.
More Info: https://clival.com/blog/better-data-for-smarter-drug-licensing-decisions